Background: Tramadol is a synthetic centrally acting analgesic used for treatment of moderate to severe acute or chronic pain. In tramadol overdose, seizures and hypotension are present. Intravenous lipid emulsion (ILE) is considered as effective treatment for local anesthetic-induced cardiovascular collapse, and treating overdoses of parasiticides, and herbicides. Aim: the aim of this work was to evaluate the role of ILE in acute tramadol toxicity as regarding hemodynamic instability and seizures in adult male albino rats. Materials and Methods: Eighty adult male albino rats were divided into five groups: Group I (control group). Group II normal saline, Group III lipid emulsion group (subdivided into ILE10, ILE19 subgroups). Group IV (tramadol treated group). Group V: (tramadol and normal saline treated group). Group VI: divided into tramadol+ILE10 and tramadol+ILE19 subgroups. Measurement of blood pressure, monitoring of heart rate and observation for occurrence of seizures were recorded. Results: Different doses of ILE significantly normalized DBP and HR. After infusion of ILE 20%, MAP was significantly stabilized. The ILE10 group had higher MAP at 6 hours, whereas such effect was seen only in ILE19 after 24 hours. There was a decrease in seizures occurrence in ILE treated groups. Serum CPK levels were significantly raised after tramadol toxicity and reduced to normal ranges when ILE was administered in both doses. Tramadol causes Hemodynamic instability and appearance of seizures after once administration (150 mg/kg). ILE could significantly normalize Hemodynamic and seizures of tramadol toxicity. In conclusion: Single administration of tramadol in a dose of 150 mg/kg causes hemodynamic instability and appearance of seizures in adult male albino rats. ILE10 and ILE 19 could significantly normalize hemodynamic and ameliorated the occurrence of tramadol toxicity induced seizures. It is recommended: to do further in vivo studies needed to evaluate role of ILE in chronic tramadol using. Clinicians can consider administration of ILE in resuscitation protocols toxicities causing hemodynamic compromise but the potential risks of administering the quite high doses of ILE are uncertain and needs more researches.
INTRODUCTION
ramadol is a synthetic centrally acting analgesic used in treatment of moderate to severe acute or chronic pain (Nossaman et al., 2010). Tramadol is structurally similar to morphine and codeine with effects similar to those of codeine and 10 times less than morphine. Its analgesic effects recognized as a weak μ-opioid receptor agonist with norepinephrine and serotonin reuptake inhibitor. Its opioid-like effect is the cause of tramadol misuse is a public health concern The mechanism of action of tramadol has not yet to be fully clarified, but it is supposed to work through of opioid and non-opioid mechanisms. Tramadol and its metabolite bind to the μ -opioid receptors in the brain, only 1/6000 of that of morphine although its selectivity for this sub-type of receptor is greater than that of morphine. Tramadol modulates the gamma-aminobutyric acid GABAergic, noradrenergic and serotonergic systems (Mehrpour, 2005& Volpe et al., 2011), as it inhibits reuptake of 5-hydroxytryptamine (5-HT) and noradrenaline. The late mechanism is important since the analgesic effects of tramadol are not fully antagonized by the μ -opioid receptor antagonist naloxone (Gasse et al., 2000) . Tramadol multi-formulation availability and its low serious side effect except at high doses and in prolonged use, increased its short and T long term use in communities and hospitals (Shipton, 2000) . In tramadol overdose, the most serious and significant adverse effects are dizziness, headache, agitation, movement disorders, seizures and hypotension. Less common findings are central nervous system depression, tachycardia, nausea and vomiting The aim of this work is to evaluate tramadolinduced hemodynamic instability (heart rate & blood pressure) and tramadol-induced seizures in adult male albino rats and to evaluate the role of ILE in acute tramadol toxicity in adult male albino rats.
MATRIALS AND METHOD Chemicals: 1-Tramadol tablets: each one contains 225 mg tramadol hydrochloride obtained from October Pharma Company. 2-Intravenous lipid emulsion (ILE): SMOFlipid™ 20%, 500 mL of injectable emulsion that is a white homogeneous emulsion, obtained from Fresenius Kabi Company, Austria.It is composed of (6% soybean oil, 6% medium chain triglycerides, 5% olive oil and 3% fish oil).
Animals:
All animals received human care in compliance with the Animal Care Guidelines and Ethical Regulations in accordance with ''The Guide for the Care and Use of Laboratory Animals'' (Institute of Laboratory Animal Resources, 1996). Experimental design:
The study was carried out on 80 adult male albino rats, their weights ranging from 180-220 gm for each, they were obtained from the Animal House of the Faculty of Veterinary Medicine , Zagazig University. The study had been conducted in Animal House of the Faculty of Medicine, Zagazig University. Before commencing the experiment, all animals were subjected to 14 days period of passive preliminaries in order to adapt themselves to their new environment, to ascertain their physical well-being and to exclude any diseased animals. The animals were housed in plastic cages free from any source of chemical contamination under controlled conditions with an ambient temperature range of 22 ± 2 oC, relative humidity of 50 ±5% and a 12 hours lightcycle. Soft wood shavings were used for bedding and changed during the cleaning of cages on alternate days. The rats received balanced food rich in all stuffs necessary to maintain their health before and during drug administration. It consisted of bread, barley and milk. Water was offered in separate clean containers.
The rats were divided into five groups as the following: Group I (Control group): It consisted of 10 adult male albino rats. Each rat of this group received only regular diet and tap water for 48 hours. Group II normal saline group: It consisted of 10 adult male albino rats. Each rat of this group received normal saline 0.9% NaCl I.V. infusion with infusion rate of 1.5 mL/min for 30 minutes once (Jamaty et al., 2010 had higher MAP at 6 hours (P< 0.05), whereas such effect was seen only in ILE19 after 24 hours. Although there was a slight decrease in MAP by different doses of ILE within 24 hours of poisoning, this increase was not considered significant compared with tramadol + normal saline. (Table 2B ,2C and 2D).
Regarding occurrence of seizures, No observed seizures were detected in control groups (Control, Normal saline, ILE10 or ILE19). There were statistical significant differences in incidence of seizures among treated groups (Tramadol, Tramadol+Normal saline, Tramadol+ILE10 and Tramadol+ILE19) (P < 0.05). The incidence of seizures in tramadol was 80%, reduced to 50% in tramadol with normal saline group. It became 10% in tramadol + ILE10 group and 30% in tramadol + ILE19 group (Table 3) . Regarding creatinine phosphpkinase serum levels, CPK levels among Control, Normal saline, ILE10& ILE19 groups, were not statistically significant (p>0.05) (table 4 A). So, the control group was used as a control group for comparison with other treated groups. CPK levels showed a highly significant difference (p<0.001) among the different treated groups (Tramadol, Tramadol+ Normal Saline, Tramadol+ILE10& Tramadol+ILE19) in comparison to control group (table 4B) . There were highly significant elevations (P<0.001) in tramadol& tramadol+normal saline groups & a non-significant elevation (p>0.05) in tramadol+ILE10 group and a significant increase (p<0.05) in tramadol+ILE19 group when compared with the control group. Additionally, there was a significant decrease (p<0.05) in CPK serum levels in tramadol+normal saline group but highly significant reductions (p<0.001) in tramadol+ILE10& tramadol+ILE19 groups when compared with tramadol group. Also, there were significant reductions (P<0.05) in tramadol+ILE10& tramadol+ILE19 groups when compared with tramadol+normal saline group. There was a significant elevation (p<0.05) in tramadol+ILE19 group when compared with tramadol+ILE10 group. Regarding Body Weight mean values, Paired t-test regarding showed non-significant differences (p>0.05) before and after treatment as regard all studied groups. Mortality rate in this study was zero as no deaths were recorded in any group of the study. Number of sacrificed rats for each group was 10 rats; ANOVA: Analysis of variance; SD: Standard Deviation; p>0.05: non-significant. Number of sacrificed rats for each group was 10 rats; ANOVA: Analysis of variance; SD : Standard Deviation; p>0.05 : non-significant. Number of sacrificed rats for each group was 10 rats; ANOVA: Analysis of variance; SD : Standard Deviation; p>0.05 : non-significant. Number of sacrificed rats for each group was 10 rats; TN: Total number of rats; N: Number of rats with seizures. Number of sacrificed rats for each group was 10 rats; SD : Standard Deviation; p>0.05 : nonsignificant. Number of sacrificed rats for each group was 10 rats; SD: Standard Deviation; P>0.001: Highly significant; Significant of LSD: a= significant VS Control. b= significant VS Tramadol. c= significant VS Tramadol+ saline d= significant VS Tramadol +ILE10 DISCUSSION At different time points (after 30 minutes, 6 hours, 24 hours and 48 hours of treatment administration), While SBP measurements showed non-significant differences among the different treated group in comparison to control group, DPB showed highly significant differences among the different treated groups in comparison to control group. Injections of tramadol significantly decreased DBP. Different doses of ILE could significantly normalize DBP, whereas effects of ILE10 were more powerful on such phenomenon especially 6 hours after administration. However, the changes in DBP in tramadol + normal saline group did not return to normal level even after 48 hours. The observations of the present work were in line with the results of Ekemenet al., (2008) study, which stated that tramadol did not affect systolic blood pressure when used for prevention of postoperative pain in children and with Vahabzadeh et al., (2013), who reported that, although ILE did not have major effect on systolic blood pressure, It normalized diastolic blood pressure and its maximum effect was achieved 6 hours post 12 mL/kg dose administration. The mechanism by which tramadol reduced DBP may be partially through nitric oxide synthesis/release by endothelial cells as At different time points (after 30 minutes, 6 hours, 24 hours and 48 hours of treatment administration), MAP showed highly significant differences among the different treated groups in comparison to control group. The results of this study showed that after infusion of ILE 20%, MAP was significantly stabilized in groups receiving ILE. The ILE10 group had higher MAP at 6 hours, whereas 
Occurrence of seizures:
The results of present study showed that seizures occurrence was observed in 50% of the group treated with tramadol alone, while there was a considerable decrease in convulsions occurrence in groups that were treated with ILE. However, this effect of ILE was best revealed in the dose of 10 mL/kg. The observations of the present study were agreed with the results of Vahabzadeh et al., (2013), who showed that ILE prevented tramadol-related seizures in doses of 6 and 12 mL/kg. It has been shown that the appearance of seizures with tramadol is not dose dependent (Talaie et al., 2009).Seizures due to tramadol use may occur in both overdose and within therapeutic dose range (Jick et al., 1998) . Fewer than 1% of consumers have a presumed incident seizure right after their first tramadol prescription. Risk of seizure claim increases two-to six-fold between users adjusted for selected comorbidities and concomitant drugs. Risk of seizure is highest among those aged 25-54 years, those with more than four tramadol prescriptions, and those with a history of alcohol abuse, stroke, or head injury (Gardner, 2000) . Seizures caused by tramadol are most often tonic-clonic seizures, more commonly known as grand-mal seizures. Also when taken with selective serotonin reuptake inhibitor (SSRIs), there is an increased risk of serotonin toxicity, which can be fatal (Gillman, 2005) . The GABA receptor inhibition caused by tramadol can be attributed to its opioid receptor agonist effect (Rehni et al., 2008) , and continuing this agonist activity on opioid receptor has been proven to cause seizure due to GABA inhibition (Miura et al., 2007) (2012) stated that ILE infusion seizures and dysrhythmias experienced in patient with TCA toxicity were terminated within 2 minutes of the second ILE bolus, however, they weren't rapidly to traditional treatment represented by benzodiazepines and sodium bicarbonate. The clinical effect of ILE infusion on reversal of CNS and cardiac toxicity with serial LA plasma concentrations or other lipophilic drugs is mainly attributed to its mechanism of action by re-establishing equilibrium within an expanded plasma lipid phase (sink) with subsequent reduction in free drug levels (Cave and Harvey, 2009), also by extracting lipophilic drugs from tissues or by counteracting local anesthetic inhibition of myocardial fatty acid oxygenation (Corman and Skledar, 2007). Regarding effect of ILE on tramadol-induced seizures can be also attributed to the lipid sink theory as ILE removes tramadol from the tissues preventing it from coupling to its receptors (Vahabzadeh et al., 2013) .
In this study, Serum CPK levels were dramatically raised after tramadol toxicity, whereas ILE could powerfully reduce it to normal ranges when administered in both doses (10 and 19 mL/kg), but the decrease was more significant with dose of 10 mL/kg. The previous result agreed with Afshari and Ghooshkhanehee, (2009) and Tashakori and Afshari, (2010), who reported dramatic rise of CPK in cases with tramadol overdose because of frequent seizures. While Vahabzadeh et al., (2013) stated that ILE could powerfully reduce it to normal ranges when administered in higher doses (12 and 18 mL/kg). The serum level of skeletal muscle enzymes is considered as a marker of muscle tissue function and varies in both pathological and physiological conditions. Increased level of these enzymes indicates acute or chronic cellular necrosis and tissue damage (Brancaccio et al., 2007) . In tissues and cells that consume ATP rapidly, as skeletal muscle, CPK acts as an energy reservoir for the rapid ATP buffering and regeneration (Wallimann and Hemmer 1994). Total CPK levels depend on age, gender, race, physical activity, muscle mass, and climatic condition (Stomme et al., 2004) . Young adult males have high serum levels of CPK, which decline to some extent with age during the geriatric period (Borges and EssenGustavsson, 1989 , Tietz et al., 1992). The serum CPK level can be elevated from the damage of the muscle tissue because of intense prolonged training. This may be a consequence of both metabolic and mechanical causes. Certainly, metabolically exhausted muscle fibers exhibit a decrease in the membrane resistance following an increase in the internal free calcium ions, which promotes the activation of the potassium channel (Fink et al., 1983) . Another mechanism could be the local tissue damage with sarcomeric degeneration from Zdisk fragmentation. CPK is an indicator of muscle necrosis, increasing with its extent 
